Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02935283 · ClinicalTrials.gov registry record

Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders

A clinical trial of Urea Cycle Disorders, sponsored by Children's National Research Institute.

Recruiting
Registry status
56
Enrollment target
1
Study location

NCT02935283 is a study of Urea Cycle Disorders that is actively recruiting participants, run by Children's National Research Institute. The registered enrollment target is 56 participants, below the 383-participant average among 4 other Urea Cycle Disorders trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02935283, a study of Urea Cycle Disorders, is actively recruiting participants, sponsored by Children's National Research Institute.

RECRUITING
Registry status
56 participants
Enrollment target
1
Study location

Study Summary

In proximal urea cycle disorders (UCD), particularly ornithine transcarbamylase deficiency (OTCD), hyperammonemia (HA) causes increased brain glutamine (Gln) which perturbation is thought to be at the core of the neurological injury. In contrast, in distal UCD such as citrullinemia (argininosuccinate synthetase deficiency; (ASSD) and argininosuccinic aciduria (argininosuccinate lyase deficiency); (ASLD) cognitive impairment and neuropsychiatric disease are common even in the absence of acute HA. As a consequence, both citrulline and argininosuccinate (ASA) or their metabolic products have been implicated as neurotoxic. In this project the investigators will use state-of- the-art neuroimaging and neuropsychological methods to investigate whether patients with OTCD have chronically elevated brain Gln and reduced myo-inositol (mI) levels that correlate with regional brain structural abnormalities and neurocognitive dysfunction. The researchers will further investigate whether during an acute episode of HA elevated brain Gln and decreased mI levels correlate with the magnitude of cytotoxic edema and whether a Gln/mI ratio threshold can be identified at which the cytotoxic edema is followed by cell loss. Finally, the researchers will investigate whether regions of brain damage in ASSD and/or ASLD are distinct from those in OTCD and compare brain Gln levels in ASSD and ASLD in the absence of HA to those in OTCD. The investigators will also seek to determine if brain citrulline and ASA can be identified in the brains of patients with distal UCD and whether they correlate with brain abnormalities seen in MRI and neuropsychological testing. This project will elucidate the chronology of brain pathology both in acute hyperammonemia and chronic UCD and whether, proximal and distal UCD differ in their pathophysiology of brain damage.

Conditions Studied

Interventions

  • PROCEDURE MRI
  • BEHAVIORAL Behavioral

Study Locations (1)

District of Columbia

  • Children's Research Institute - Washington D.C.

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2016-08
Est. Completion 2025-12

What the Registry Record Tells You About NCT02935283

The ClinicalTrials.gov registry entry for NCT02935283 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 383-participant average among 4 other Urea Cycle Disorders trials with a reported enrollment target (85% lower). The listed sponsor is Children's National Research Institute, which has 92 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Urea Cycle Disorders appearing as the primary indexed condition, and to 2 interventions - of which MRI is the first listed.

NCT02935283 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.

Frequently Asked Questions

What is clinical trial NCT02935283 about?

NCT02935283 is a clinical study titled "Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders". In proximal urea cycle disorders (UCD), particularly ornithine transcarbamylase deficiency (OTCD), hyperammonemia (HA) causes increased brain glutamine (Gln) which perturbation is thought to be at the core of the neurological injury. In contrast, in distal UCD such as citrullinemia (argininosuccinat...

What is the current status of trial NCT02935283?

This trial is currently recruiting. The enrollment target is 56 participants. The study started on 2016-08. Estimated completion is 2025-12.

What conditions does trial NCT02935283 study?

This clinical trial studies the following conditions: Urea Cycle Disorders.

What interventions are being tested in trial NCT02935283?

The interventions under investigation include: MRI (PROCEDURE), Behavioral (BEHAVIORAL).

Who is sponsoring clinical trial NCT02935283?

This trial is sponsored by Children's National Research Institute, which has 92 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02935283 being conducted?

This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Urea Cycle Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.